Detalhe da pesquisa
1.
Peptide-HLA-based immunotherapeutics platforms for direct modulation of antigen-specific T cells.
Sci Rep
; 11(1): 19220, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584159
2.
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies.
Clin Cancer Res
; 26(8): 1953-1964, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31964784